Robert F. Kennedy Jr.’s presidential campaign has unveiled a “Transparency and Open Science Policy” aimed at shaking up the status quo in federal health agencies. The policy’s core tenet is demanding full transparency from the NIH, CDC, and FDA, requiring the release of internal studies, data, and communications related to public health decisions. This extends to reforming Medicaid by granting states more flexibility and advocating for alternative treatments, like nutritional interventions, alongside conventional medicine. Furthermore, Kennedy proposes establishing independent review boards to scrutinize agency actions and regulatory decisions, suggesting a move toward deregulation and decentralized healthcare. While emphasizing data integrity and potentially expanding environmental health research, the policy also aligns with Kennedy’s controversial stance on vaccine safety, challenging established scientific consensus and highlighting potential conflicts of interest within regulatory bodies, making it a potentially disruptive force in the landscape of public health policy.
This policy announcement details RFK Jr.’s commitment to transparency and independent review in federal health agencies, particularly regarding data and decision-making related to public health, though it reinforces his controversial views on vaccine safety.
https://www.cbsnews.com/news/rfk-jr-transparency-policy-medicaid-nih